Treatment of keratosis pilaris rubra with 577-nm pro-yellow laser

Basit Öğe Kaydı
dc.contributor.authorTemiz, Selami Aykut
dc.contributor.authorAtaseven, Arzu
dc.contributor.authorDursun, Recep
dc.date.accessioned2024-02-23T14:24:30Z
dc.date.available2024-02-23T14:24:30Z
dc.date.issued2022
dc.departmentNEÜen_US
dc.description.abstractObjective Keratosis pilaris rubra (KPR) is a rare group of idiopathic hereditary disorders of keratinization, and it is considered as variants of keratosis pilaris. It is characterized by a well-defined erythema and small, keratotic follicular papules that are seen on the cheeks and preauricular area. Keratosis pilaris rubra is an aesthetically distressed situation, and especially vascular erythema is the most common complaint. In recent years, pro-yellow (577 nm) laser, laser system with yellow light wavelength, has been used as an alternative for seeking more effective treatment especially in vascular lesions. However, in the literature, pro-yellow laser therapy has never been used before in keratosis pilaris rubra. Therefore, we wanted to evaluate the effectiveness of the pro-yellow laser in keratosis pilaris rubra patients. Materials and Methods In our study, four patients with keratosis pilaris rubra treated with pro-yellow laser in our Cosmetology Unit between December 2017 and March 2019 were evaluated. The first session was started with 20 j/cm(2) and the dose increased 2 j/cm(2) at each session. The dose was increased up to 26 j/cm(2), a total of four sessions (20-22-24-26 j/cm(2)) was applied in treatment. All the sessions were used in treatment scanner mode. Results Objectifying a clearance of erythema >75% was clinically evident in three patients, in the fourth patient, erythema regressed approximately 50%. There has been no recurrence of the lesions after a minimum three months follow-up. There was no permanent side effect in any patient. Conclusion Pro-yellow laser is a well option for the treatment of keratosis pilaris rubra, and we think that it could be a safety choice therapy. In addition, a well tolerance to treatment and a low incidence of serious side effects make it a very reliable therapy. Further clinical studies are needed to improve our findings.en_US
dc.identifier.doi10.1111/jocd.15088
dc.identifier.endpage3816en_US
dc.identifier.issn1473-2130
dc.identifier.issn1473-2165
dc.identifier.issue9en_US
dc.identifier.pmid35569135en_US
dc.identifier.scopus2-s2.0-85130887877en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage3814en_US
dc.identifier.urihttps://doi.org/10.1111/jocd.15088
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13970
dc.identifier.volume21en_US
dc.identifier.wosWOS:000802930900001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofJournal Of Cosmetic Dermatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectKeratosis Pilaris Rubraen_US
dc.subjectLaser Treatmenten_US
dc.subjectPro-Yellow Laseren_US
dc.titleTreatment of keratosis pilaris rubra with 577-nm pro-yellow laseren_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu